Dual SGLT-1 and SGLT-2 inhibition improves left atrial dysfunction in HFpEF
David Bode(German Centre for Cardiovascular Research), Felix Hohendanner(German Centre for Cardiovascular Research), Burkert Pieske(German Centre for Cardiovascular Research), Christian U. Oeing(Johns Hopkins University), Frank R. Heinzel, Raphael Dahmen(Sanofi (Germany)), Alessio Alogna(Deutsches Herzzentrum der Charité), Nicola Beindorff(Charité - Universitätsmedizin Berlin), Daniel Messroghli(German Centre for Cardiovascular Research), Lukas Semmler(German Centre for Cardiovascular Research), Niklas Hegemann(German Centre for Cardiovascular Research), Uwe Primeßnig(Medical University of Graz), David R. Powell(Lexicon Pharmaceuticals (United States)), Hartmut Ruetten(Sanofi (Germany)), Paulina Wakula(German Centre for Cardiovascular Research)
Cited by 112
Related Papers
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC
|European Heart Journal|2012|6.9k
ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012
|European Journal of Heart Failure|2012|2.6k
How to diagnose heart failure with preserved ejection fraction: the HFA–PEFF diagnostic algorithm: a consensus recommendation from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC)
|European Heart Journal|2019|1.8k
Cardioprotection and lifespan extension by the natural polyamine spermidine
|Nature Medicine|2016|1.1k
Mitochondrial function as a therapeutic target in heart failure
|Nature Reviews Cardiology|2016|786